Cargando…

Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells

BACKGROUND: The human dicer1 gene has been predicted to produce several mRNA variants that encode truncated Dicer1 proteins of varying lengths. One of these Dicer1 variants, Dicer1e, was recently found to be differentially expressed in breast cancer cells. Because the expression and function of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantini, Liliana P, Andino, Lourdes M, Attaway, Christopher C, Butler, Betsy, Dumitriu, Anca, Blackshaw, Aaron, Jakymiw, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141963/
https://www.ncbi.nlm.nih.gov/pubmed/25115815
http://dx.doi.org/10.1186/1476-4598-13-190
_version_ 1782331720902639616
author Cantini, Liliana P
Andino, Lourdes M
Attaway, Christopher C
Butler, Betsy
Dumitriu, Anca
Blackshaw, Aaron
Jakymiw, Andrew
author_facet Cantini, Liliana P
Andino, Lourdes M
Attaway, Christopher C
Butler, Betsy
Dumitriu, Anca
Blackshaw, Aaron
Jakymiw, Andrew
author_sort Cantini, Liliana P
collection PubMed
description BACKGROUND: The human dicer1 gene has been predicted to produce several mRNA variants that encode truncated Dicer1 proteins of varying lengths. One of these Dicer1 variants, Dicer1e, was recently found to be differentially expressed in breast cancer cells. Because the expression and function of the Dicer1e protein variant has not been well characterized and the underlying molecular mechanisms for the development of oral squamous cell carcinomas (OSCCs) are poorly understood, the present study sought to characterize the biological role of Dicer1e and determine its relationship, if any, to OSCC pathogenesis. METHODS: Western blot analyses were used to examine Dicer1e expression levels in a panel of oral cancer cells/tissues and during epithelial-mesenchymal transition (EMT), followed by 5′/3′-RACE analyses to obtain the full-length Dicer1e transcript. Biochemical fractionation and indirect immunofluorescent studies were performed to determine the cellular localization of Dicer1e and the effects of Dicer1e silencing on cancer cell proliferation, clonogenicity, and drug sensitivity were also assessed. RESULTS: Dicer1e protein levels were found to be overexpressed in OSCC cell lines of epithelial phenotype and in OSCC tissues with its levels downregulated during EMT. Moreover, the Dicer1e protein was observed to predominantly localize in the nucleus. 5′/3′-RACE analyses confirmed the presence of the Dicer1e transcript and silencing of Dicer1e impaired both cancer cell proliferation and clonogenicity by inducing either apoptosis and/or G2/M cell cycle arrest. Lastly, Dicer1e knockdown enhanced the chemosensitivity of oral cancer cells to cisplatin. CONCLUSION: The expression levels of Dicer1e influence the pathogenesis of oral cancer cells and alter their response to chemosensitivity, thus supporting the importance of Dicer1e as a therapeutic target for OSCCs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-4598-13-190) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4141963
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41419632014-08-24 Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells Cantini, Liliana P Andino, Lourdes M Attaway, Christopher C Butler, Betsy Dumitriu, Anca Blackshaw, Aaron Jakymiw, Andrew Mol Cancer Research BACKGROUND: The human dicer1 gene has been predicted to produce several mRNA variants that encode truncated Dicer1 proteins of varying lengths. One of these Dicer1 variants, Dicer1e, was recently found to be differentially expressed in breast cancer cells. Because the expression and function of the Dicer1e protein variant has not been well characterized and the underlying molecular mechanisms for the development of oral squamous cell carcinomas (OSCCs) are poorly understood, the present study sought to characterize the biological role of Dicer1e and determine its relationship, if any, to OSCC pathogenesis. METHODS: Western blot analyses were used to examine Dicer1e expression levels in a panel of oral cancer cells/tissues and during epithelial-mesenchymal transition (EMT), followed by 5′/3′-RACE analyses to obtain the full-length Dicer1e transcript. Biochemical fractionation and indirect immunofluorescent studies were performed to determine the cellular localization of Dicer1e and the effects of Dicer1e silencing on cancer cell proliferation, clonogenicity, and drug sensitivity were also assessed. RESULTS: Dicer1e protein levels were found to be overexpressed in OSCC cell lines of epithelial phenotype and in OSCC tissues with its levels downregulated during EMT. Moreover, the Dicer1e protein was observed to predominantly localize in the nucleus. 5′/3′-RACE analyses confirmed the presence of the Dicer1e transcript and silencing of Dicer1e impaired both cancer cell proliferation and clonogenicity by inducing either apoptosis and/or G2/M cell cycle arrest. Lastly, Dicer1e knockdown enhanced the chemosensitivity of oral cancer cells to cisplatin. CONCLUSION: The expression levels of Dicer1e influence the pathogenesis of oral cancer cells and alter their response to chemosensitivity, thus supporting the importance of Dicer1e as a therapeutic target for OSCCs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-4598-13-190) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-13 /pmc/articles/PMC4141963/ /pubmed/25115815 http://dx.doi.org/10.1186/1476-4598-13-190 Text en © Cantini et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Cantini, Liliana P
Andino, Lourdes M
Attaway, Christopher C
Butler, Betsy
Dumitriu, Anca
Blackshaw, Aaron
Jakymiw, Andrew
Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells
title Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells
title_full Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells
title_fullStr Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells
title_full_unstemmed Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells
title_short Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells
title_sort identification and characterization of dicer1e, a dicer1 protein variant, in oral cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141963/
https://www.ncbi.nlm.nih.gov/pubmed/25115815
http://dx.doi.org/10.1186/1476-4598-13-190
work_keys_str_mv AT cantinililianap identificationandcharacterizationofdicer1eadicer1proteinvariantinoralcancercells
AT andinolourdesm identificationandcharacterizationofdicer1eadicer1proteinvariantinoralcancercells
AT attawaychristopherc identificationandcharacterizationofdicer1eadicer1proteinvariantinoralcancercells
AT butlerbetsy identificationandcharacterizationofdicer1eadicer1proteinvariantinoralcancercells
AT dumitriuanca identificationandcharacterizationofdicer1eadicer1proteinvariantinoralcancercells
AT blackshawaaron identificationandcharacterizationofdicer1eadicer1proteinvariantinoralcancercells
AT jakymiwandrew identificationandcharacterizationofdicer1eadicer1proteinvariantinoralcancercells